Page 8 - Anjali Singh

Aster DM Healthcare Q4FY26 net profit jumps 77%; revenue rises 18%

Strong growth in hospitals, clinics and labs drives earnings; margins expand on operating leverage and cost discipline across key regional clusters

Castrol India banks on pricing, rural push to navigate cost pressures

Castrol India is relying on price hikes and rural expansion to offset rising costs, while sustaining growth through steady demand and market share gains across segments

Piramal Pharma bets on FY27 rebound; expects mid-teens growth, margin gains

Piramal Pharma expects a recovery in FY27 with mid-teens revenue growth and improved margins, supported by CDMO rebound, stronger order inflows, and global supply chain shifts

Ceat Q4 profit more than doubles on global push, revenue rises 23%

Tyre maker posts strong earnings on international growth and improved mix, but flags near-term margin pressure from rising raw material costs

Castrol India Q1 revenue rises 9%, profit up 4% amid steady demand

Castrol India posted steady Q1 FY26 results with higher revenue and profit growth, supported by robust rural and industrial demand, even as it flagged currency volatility & raw material cost pressures

India-New Zealand FTA to boost auto exports, spur EV investments

Industry stakeholders believe the move could provide a meaningful boost to India's auto exports, particularly at a time when companies are looking to diversify markets and scale global operations

Cohance Lifesciences appoints Umang Vohra as chairman, CEO; Sharma exits

Pharma veteran Umang Vohra to lead Advent-backed Cohance Lifesciences as chairman and CEO, succeeding Vivek Sharma amid efforts to revive growth and address regulatory challenges

Mahindra ranks 25th in top 100 valuable global auto brands: Report

Eight Indian auto brands feature in global top 100, with Mahindra leading at 25th as strong SUV demand, EV push and global expansion drive rising brand value

IKS eyes US healthcare growth with TruBridge deal, targets AI synergies

IKS Health's proposed TruBridge acquisition aims to integrate EHR and workflow tools, drive cost efficiencies, and unlock AI-led gains in the US healthcare market

Classic Legends reroutes exports to Europe amid US uncertainties

Classic Legends shifts export focus to Europe and other markets while turning profitable, navigating US uncertainty and supply chain disruptions

Tesla bets on ecosystem-first strategy to unlock India EV market

Tesla is prioritising charging, service and ownership ecosystem in India before scaling volumes, aiming to overcome structural barriers in the nascent EV market

India leads global shift to AI-led healthcare adoption, says BCG study

The report also points to a shift towards hybrid healthcare models, where patients prefer AI-assisted human care rather than relying solely on doctors or machines

Stakeholders flag MRP distortions in healthcare, call for reforms

Industry experts and consumer groups highlight inflated pricing and lack of transparency in healthcare MRPs, urging regulatory intervention for fair pricing

Lilly backs regulatory action after fake Mounjaro seizure in Gurugram

Drugmaker highlights patient safety risks and pledges cooperation with authorities after seizure of suspected counterfeit Mounjaro products in Gurugram

India's car market flips from glut to constraint, shows Fada data

Passenger vehicle demand outstrips supply in FY26, tightening inventories and extending wait times as automakers struggle to match strong retail momentum

Rubicon Research sharpens India play with focus on CNS: CEO Parag Sancheti

Currently, more than 95 per cent of Rubicon's revenue comes from the United States (US), where the company has built a generics and specialty portfolio

FIEO urges RBI to provide liquidity support amid West Asia conflict

India's export sector has held up well despite a year marked by geopolitical tensions, tariff volatility, said SBI's Ghosh

Lupin arm settles US antitrust litigation with Humana for $30 million

Lupin says its US subsidiary will pay $30 million to Humana to settle antitrust claims, adding the amount has already been provided for and does not impact current financials

Commercial vehicle growth seen moderating to 6-7% in FY27 amid headwinds

After nearly 12% growth in FY26, CV industry to grow around 6-7% in FY27 amid headwinds from oil price volatility, monsoon-linked rural demand and macroeconomic pressures

Volkswagen bets on pricing, buyback as Taigun starts at ₹10.99 lakh

Volkswagen India launches updated Taigun at Rs 10.99 lakh, introduces a buyback programme and adds features to attract buyers amid rising competition in the compact SUV segment